Kristen Stewart analyst

Currently out of the existing stock ratings of Kristen Stewart, 55 are a BUY (53.4%), 15 are a SELL (14.56%), 33 are a HOLD (32.04%).

Kristen Stewart

Work Performance Price Targets & Ratings Chart

Analyst Kristen Stewart, carries an average stock price target met ratio of 73.2% that have a potential upside of 23.21% achieved within 337 days. Previously, Kristen Stewart worked at C. L. KING, DEUTSCHE BANK, BARCLAYS.

Kristen Stewart’s has documented 210 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TFX, Teleflex at 04-Nov-2024.

Wall Street Analyst Kristen Stewart

Analyst best performing recommendations are on AVNS (AVANOS MEDICAL).
The best stock recommendation documented was for AVNS (AVANOS MEDICAL) at 4/13/2020. The price target of $30 was fulfilled within 1 day with a profit of $1.62 (5.71%) receiving and performance score of 57.08.

Average potential price target upside

ABT Abbott Laboratories BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp CNMD CONMED EW Edwards Lifesciences Corp HRC Hill-Rom Holdings JNJ Johnson & Johnson MDT Medtronic PLC SYK Stryker TFX Teleflex TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings AVNS Avanos Medical CSII Cardiovascular Systems SILK Silk Road Medical AXNX Axonics Modulation Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Jan-2017

$135

$32.39 (31.57%)

$135

12 days ago
(08-Sep-2026)

25/33 (75.76%)

$29.48 (27.94%)

311

Buy Since 28-Jul-2026

$125

$22.39 (21.82%)

$117

1 months 23 days ago
(28-Jul-2026)

3/4 (75%)

$17.73 (16.53%)

149

Buy Since 06-Jun-2019

$112

$9.39 (9.15%)

$136

2 months 3 days ago
(17-Jul-2026)

16/21 (76.19%)

$11.32 (11.24%)

391

Buy Since 29-Jun-2017

$112

$9.39 (9.15%)

$146

2 months 3 days ago
(17-Jul-2026)

25/30 (83.33%)

$11.32 (11.24%)

489

Buy Since 19-Sep-2024

$118

$15.39 (15.00%)

$115

2 months 3 days ago
(17-Jul-2026)

4/8 (50%)

$17.32 (17.20%)

118

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?